资讯

.NET 10 Release Candidate 1: Follow-up for Entity Framework Core

Microsoft ORM Mapper learns column types Vector and JSON in Microsoft SQL Server 2025. At the same time, there is a first ...

Novo Nordisk: A Pharma Leader With Growth Potential And Portfolio-Defensive Appeal

Discover why Novo Nordisk is a top buy with strong GLP-1 drug growth, robust fundamentals, and defensive value.